Saks, Nordstrom, Ma...
Health Care: Drugs
ADVENTRX Pharmaceuticals Inc. (ANX: AMEX)
$0.65 -0.01 | -1.52%
05/21/13 - 03:59 PM ET
Company Income Statement
Income Statement data is not available for ANX.
Portfolios with ANX
- Portfolio NameUser Type
- UserLosingAllmyMoney
- Userdanielyrs
- UserAbdulaziz
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Uservlady 1
- Usertesting
- Contributor5 Stocks Under-$10 Setting ...
- ContributorBreakout Stocks Of The Week...
- ContributorHot Biotech Trades for Seco...
Latest ANX Headlines from TheStreet
- 4 Biotech Stocks Under $10 Moving Higher 07.12.12 | 01:07 pm
- For Biotech, 'Fail' is Making a Big Comeback 03.12.12 | 08:03 am
- ADVENTRX Stock Gaps Down On Today's Open (ANX) 11.11.11 | 08:11 am
- 5 Stocks Under $10 Setting Up to Trade Higher 09.15.11 | 01:09 pm
- 5 Stocks Setting Up to Break Out 09.09.11 | 03:09 pm
- ADVENTRX Stock Hits New 52-Week Low (ANX) 08.10.11 | 09:08 am
- Adventrx: FDA Rejects Lung Cancer Drug 08.10.11 | 07:08 am
- ADVENTRX Stock Gaps Down On Today's Open (ANX) 08.08.11 | 10:08 am
- Biotech Stock Mailbag: Sangamo Biosciences 07.22.11 | 05:07 am
- Biotech Stock Live Chat 07.15.11 | 12:07 pm
Press Releases for ANX
- ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX" - PR Newswire 03.11.13 | 08:03 am
- ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX" - PR Newswire 02.28.13 | 05:02 pm
- Adventrx To Develop ANX-188 For Complications Of Arterial Disease - PR Newswire 02.28.13 | 04:02 pm
- ADVENTRX Reviews Data Supporting Development Of ANX-188 In New Indications - PR Newswire 02.26.13 | 08:02 am
- ADVENTRX To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4 - PR Newswire 02.25.13 | 08:02 am
- ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188 - PR Newswire 02.11.13 | 08:02 am
- ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12 - PR Newswire 02.05.13 | 08:02 am
- ADVENTRX Initiates Pivotal Phase 3 Study Of ANX-188 - PR Newswire 01.30.13 | 07:01 am
- ADVENTRX Announces Appointment Of Chief Financial Officer - PR Newswire 01.04.13 | 08:01 am
- ADVENTRX To Present At The 6th Annual OneMedForum Emerging Company Finance Conference On January 8 - PR Newswire 01.02.13 | 08:01 am
Partner Headlines for ANX
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 12.19.11 | 09:12 am
- Why CytRx Corporation Is Still A Big Biotech 'If' Play - Seeking Alpha 12.14.11 | 09:12 am
- Blue Horseshoe - Or Someone - Likes Anaconda Mining; Shares Pop 20% After Selling Iron Ore Assets - NASDAQ 12.07.11 | 06:12 pm
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 12.02.11 | 09:12 am
- 5 Healthcare Stocks To Consider - Seeking Alpha 09.01.11 | 08:09 am
- Company News for August 11, 2011 - Corporate Summary - Zacks 08.11.11 | 10:08 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.10.11 | 09:08 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 07.21.11 | 09:07 am
- Adventrx Pharmaceuticals: Undervalued Based on Product Approval Potential - Seeking Alpha 07.21.11 | 08:07 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
